Guidance Offered for Improving Diversity in Multiple Myeloma Trials
WEDNESDAY, March 10, 2021 -- In an initiative from the Dana-Farber Cancer Institute in Boston, the U.S. Food and Drug Administration, and the American Association for Cancer Research, published online Feb. 18 in Blood Cancer Discovery,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Myeloma | Pharmaceuticals